Free Consultation: (425) 802-9052Tap to Call This Lawyer
Kelvin Kesse

Kelvin Kesse

Securities, Public Company and Corporate Law Attorney
  • Business Law, Securities Law
  • District of Columbia, Massachusetts, North Carolina, Texas, Washington
Badges
Claimed Lawyer ProfileSocial Media
Biography

I am the founding partner of Kesse PLLC, a corporate law firm. Prior to founding Kesse PLLC, I worked at the biggest law firms in the country.

My practice focuses on securities, capital markets, SEC reporting, emerging companies and startups, and general corporate law. I regularly advise clients on public and private securities offerings and financings, including U.S.-Canadian cross-border offerings and other foreign private issuer offerings. I assist clients with IPOs, Regulation A+ offerings, direct listings, follow-on/secondary offerings, private placements, crowdfunding, private company financings, pre-IPO counseling, SPAC formations, IPOs and business combinations (deSPACs), tender offers, emerging company and startup financings, SEC reporting and compliance and stock exchange listing and compliance.

I work with clients all over the U.S. and internationally.

My representative transactions include the following:

Represented a Nasdaq-listed commercial-stage biotech company in its $345 million IPO, a $244 million follow on offering, and SEC periodic reporting.

Represented a Nasdaq-listed developer of a wearable, non-invasive continuous glucose monitor in its IPO.

Representing a Nasdaq-listed clinical-stage biopharmaceutical company in its $350 million follow-on public offering.

Represented a Nasdaq-listed molecular diagnostics company in its purchase of a private company for approximately $2.15 billion.

Represented a biopharmaceutical company in its $5.35 billion business combination.

Represented a Nasdaq-listed clinical stage immuno-oncology company in its $2.26 billion acquisition by a public company.

Represented a Nasdaq-listed late-stage clinical company in its “At-the-Market” offering and SEC periodic filings.

Represented an NYSE-listed life sciences company focused on biopsy diagnostics for the early detection of cancer in its $40.25 million follow-on offering.

Represented a biotechnology company in its direct listing.

Practice Areas
Business Law
Business Contracts, Business Dissolution, Business Finance, Business Formation, Mergers & Acquisitions
Securities Law
Additional Practice Areas
  • Capital Markets
  • Venture Capital
  • Emerging Companies and Startups
  • Public Company Advisory and Compliance
  • SEC Filings
Fees
  • Free Consultation
    Available for free 30 minute consultation
  • Credit Cards Accepted
Jurisdictions Admitted to Practice
District of Columbia
District of Columbia Bar
Placeholder image for jurisdictions.
Massachusetts
Massachusetts Board of Bar Overseers
Placeholder image for jurisdictions.
North Carolina
North Carolina State Bar
Placeholder image for jurisdictions.
Texas
State Bar of Texas
Placeholder image for jurisdictions.
Washington
Washington State Bar Association
ID Number: 49770
Placeholder image for jurisdictions.
Languages
  • English: Spoken, Written
Professional Experience
Founding Partner
Kesse PLLC
- Current
I am the founding partner of Kesse PLLC, a boutique corporate law firm. Prior to founding Kesse PLLC, I worked at the biggest law firms in the country. My practice focuses on securities, capital markets, SEC reporting, emerging companies and startups, and general corporate law. I regularly advise clients on public and private securities offerings and financings, and I have significant experience with U.S.-Canadian cross-border offerings and other foreign private issuer offerings. I assist clients with IPOs, Regulation A+ offering, direct listings, follow-on/secondary offerings, private placements, private company financings, pre-IPO counseling, SPAC formations, IPOs and business combinations/deSPACs, tender offers, emerging company and startup financings, all aspects of corporate governance matters, SEC reporting and compliance, and stock exchange initial and additional listing and on-going listing requirements and compliance.
Senior Associate
Norton Rose Fulbright
-
I was a Business M&A/ Securities Senior Associate at Norton Rose Fulbright's Houston office. I assisted clients with public and private securities offerings; all aspects of corporate governance matters; public company representation; stock exchange initial listing and on-going compliance; and general corporate transactions.
Associate
Goodwin Procter LLP
-
I was an associate in Goodwin's Business Law Department and a member of its Life Sciences group. I assisted clients with public and private securities offerings (including US-Canadian cross-border transactions and foreign private issuer offerings); all aspects of corporate governance matters; public company representation (including on-going SEC reporting and compliance); stock exchange initial listing and on-going compliance; and general corporate transactions.
Associate
K&L Gates
-
I assisted clients with public and private securities offerings (and I have significant experience in US-Canadian cross-border transactions); mergers and acquisitions; all aspects of corporate governance matters; SEC reporting and compliance (’33 and ’34 Acts); stock exchange initial listing and on-going listing requirements and compliance; and general corporate transactions.
Associate
DLA Piper LLP (US)
-
Associate
Dorsey & Whitney LLP
-
Education
Harvard Law School
J.D. (2015)
-
Activities: Submissions Editor, Harvard Business Law Review President, Harvard African Law Association
Harvard Law School Logo
Professional Associations
Texas State Bar  # 24134104
Member
- Current
Placeholder image for professional associations.
Massachusetts State Bar  # 710534
Member
- Current
Placeholder image for professional associations.
DC Bar  # 1766479
Member
- Current
Placeholder image for professional associations.
North Carolina State Bar  # 58353
Member
- Current
Placeholder image for professional associations.
Washington State Bar  # 49770
Member
- Current
Placeholder image for professional associations.
Publications
Articles & Publications
Reverse Mergers: An Alternative Path to Public Listing
www.kessepllc.com
SEC Adopts Rule to Increase Transparency into Short Selling
www.kessepllc.com
SEC Adopts Rule 10c-1a to Increase Transparency in Securities Lending
www.kessepllc.com
Corporate Transparency Act
www.kessepllc.com
Websites & Blogs
Website
Website
Social Media
Contact & Map
Kesse PLLC
Houston
845 Texas Avenue
Suite 200
Houston, TX 77002
Toll-Free: (425) 802-9052
Fax: (281) 783-2960
Monday: 7 AM - 7 PM (Today)
Tuesday: 7 AM - 7 PM
Wednesday: 7 AM - 7 PM
Thursday: 7 AM - 7 PM
Friday: 7 AM - 7 PM
Saturday: 7 AM - 7 PM
Sunday: 7 AM - 7 PM
Notice: You may contact us by e-mail after regular business hours at kelvinkesse@kessepllc.com.